Fibrinolysis in Venous Thromboembolism.


Journal

Seminars in thrombosis and hemostasis
ISSN: 1098-9064
Titre abrégé: Semin Thromb Hemost
Pays: United States
ID NLM: 0431155

Informations de publication

Date de publication:
Jul 2021
Historique:
pubmed: 21 4 2021
medline: 15 12 2021
entrez: 20 4 2021
Statut: ppublish

Résumé

Fibrinolysis is of paramount importance in maintaining or regaining the patency of veins and pulmonary arteries obstructed by thrombi. Growing experimental and clinical evidence indicates that impaired fibrinolysis mediated by multiple complex mechanisms is involved in venous thromboembolism (VTE). Global plasma fibrin clot lysis markers, especially clot lysis time, have been reported to predict recurrent deep-vein thrombosis and pulmonary embolism. The current overview summarizes available data linking fibrinolysis to VTE and its long-term sequelae.

Identifiants

pubmed: 33878786
doi: 10.1055/s-0041-1725094
doi:

Substances chimiques

Fibrin 9001-31-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

480-489

Subventions

Organisme : N41/DBS/000184
ID : Jagiellonian University Medical College

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Anetta Undas (A)

Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland.
Krakow Centre for Medical Research and Technologies, John Paul II Hospital, Krakow, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH